S 
Star Lake Bioscience Co Inc Zhaoqing Guangdong 600866.SS · CNY
Consumer Staples · Shanghai · 🇨🇳 China
4.19
-2.10%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥15.90bn
FY2016FY2025
Net income
CN¥978.9m
FY2016FY2025
Free cash flow
−CN¥746.5m
FY2016FY2025
Shareholders' equity
CN¥8.22bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥15.90bn | CN¥17.33bn | CN¥17.37bn | CN¥17.49bn | CN¥4.07bn | CN¥1.12bn | CN¥1.05bn | CN¥859.1m | CN¥687.0m | CN¥679.8m |
| Gross profit | CN¥2.63bn | CN¥2.94bn | CN¥2.40bn | CN¥3.00bn | CN¥794.9m | CN¥365.8m | CN¥355.4m | CN¥200.5m | CN¥29.4m | CN¥121.4m |
| Research and development | CN¥184.1m | CN¥171.9m | CN¥181.6m | CN¥182.6m | CN¥101.5m | CN¥58.7m | CN¥53.6m | CN¥36.5m | CN¥24.9m | CN¥24.5m |
| Operating income | CN¥1.29bn | CN¥1.24bn | CN¥867.4m | CN¥1.43bn | CN¥283.6m | CN¥157.6m | CN¥163.1m | CN¥43.5m | −CN¥119.7m | CN¥64.0m |
| Net income | CN¥978.9m | CN¥943.2m | CN¥678.0m | CN¥608.3m | CN¥152.1m | CN¥148.7m | CN¥149.6m | CN¥42.3m | −CN¥158.3m | CN¥24.3m |
| Diluted earnings per share | 0.59 | 0.57 | 0.41 | 0.46 | 0.15 | 0.20 | 0.20 | 0.07 | -0.24 | 0.04 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥17.24bn | CN¥14.55bn | CN¥14.38bn | CN¥16.00bn | CN¥2.47bn | CN¥2.42bn | CN¥2.12bn | CN¥1.45bn | CN¥1.45bn | CN¥1.71bn |
| Cash and short-term investments | — | CN¥1.91bn | CN¥1.42bn | CN¥1.37bn | CN¥231.0m | CN¥232.6m | CN¥264.9m | CN¥97.7m | CN¥164.3m | CN¥140.0m |
| Total liabilities | CN¥8.79bn | CN¥6.52bn | CN¥6.73bn | CN¥9.07bn | CN¥697.7m | CN¥753.0m | CN¥595.9m | CN¥488.9m | CN¥534.6m | CN¥637.9m |
| Debt | CN¥2.37bn | CN¥2.77bn | CN¥4.40bn | CN¥4.48bn | CN¥371.0m | CN¥400.6m | CN¥355.2m | CN¥274.7m | CN¥344.9m | CN¥446.5m |
| Shareholders' equity | CN¥8.22bn | CN¥7.88bn | CN¥7.56bn | CN¥6.88bn | CN¥1.78bn | CN¥1.67bn | CN¥1.52bn | CN¥956.4m | CN¥914.1m | CN¥1.07bn |
| Shares outstanding | 1,661m | 1,661m | 1,663m | 1,317m | 1,010m | 739m | 739m | 645m | 647m | 642m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥1.29bn | CN¥2.40bn | CN¥2.03bn | CN¥1.66bn | CN¥192.6m | CN¥250.0m | CN¥213.2m | CN¥50.7m | CN¥40.1m | CN¥41.2m |
| Capital spending | −CN¥2.04bn | −CN¥638.5m | −CN¥375.8m | −CN¥452.3m | −CN¥205.1m | −CN¥289.9m | −CN¥157.4m | −CN¥33.7m | −CN¥40.6m | −CN¥40.3m |
| Free cash flow | −CN¥746.5m | CN¥1.76bn | CN¥1.65bn | CN¥1.21bn | −CN¥12.5m | −CN¥39.9m | CN¥55.8m | CN¥17.0m | −CN¥559,558 | CN¥911,534 |
| Dividends paid | −CN¥726.5m | −CN¥746.2m | −CN¥152.2m | −CN¥367.5m | −CN¥90.7m | −CN¥16.5m | −CN¥13.6m | −CN¥15.3m | −CN¥32.2m | −CN¥38.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥4.45bn | CN¥3.74bn | CN¥3.82bn | CN¥3.92bn | CN¥4.12bn | CN¥4.04bn | CN¥4.54bn | CN¥4.30bn |
| Gross profit | CN¥560.4m | CN¥286.2m | CN¥335.0m | CN¥623.6m | CN¥761.5m | CN¥907.3m | CN¥931.4m | CN¥675.8m |
| Operating income | CN¥216.5m | −CN¥32.4m | −CN¥21.3m | CN¥217.6m | CN¥474.4m | CN¥593.5m | CN¥365.4m | CN¥237.9m |
| Net income | CN¥117.6m | −CN¥46.9m | −CN¥36.2m | CN¥178.8m | CN¥362.1m | CN¥474.2m | CN¥265.9m | CN¥171.1m |
| Diluted earnings per share | 0.07 | -0.03 | -0.02 | 0.11 | 0.22 | 0.29 | 0.16 | 0.10 |
| Cash from operations | — | — | — | CN¥1.25bn | CN¥248.0m | CN¥365.0m | — | CN¥1.42bn |
| Capital spending | −CN¥626.0m | −CN¥265.0m | −CN¥495.0m | −CN¥652.0m | −CN¥621.0m | −CN¥268.0m | −CN¥349.0m | −CN¥154.0m |
| Free cash flow | — | — | — | CN¥599.0m | −CN¥373.0m | CN¥97.0m | — | CN¥1.27bn |
| Total assets | CN¥18.64bn | CN¥17.39bn | CN¥17.24bn | CN¥17.27bn | CN¥17.11bn | CN¥16.40bn | CN¥14.55bn | CN¥14.31bn |
| Cash and short-term investments | — | — | — | CN¥3.79bn | CN¥3.55bn | CN¥3.08bn | CN¥1.91bn | CN¥2.01bn |
| Debt | CN¥2.08bn | CN¥2.58bn | CN¥2.37bn | CN¥5.00bn | CN¥5.78bn | CN¥3.31bn | CN¥2.73bn | CN¥3.00bn |
| Shareholders' equity | CN¥7.65bn | CN¥8.17bn | CN¥8.22bn | CN¥8.31bn | CN¥8.13bn | CN¥8.40bn | CN¥7.88bn | CN¥7.63bn |
Financial ratios
Data as of 3 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 16.5% | 17.0% | 13.8% | 17.1% | 19.5% | 32.8% |
| Operating margin | 8.1% | 7.1% | 5.0% | 8.2% | 7.0% | 14.1% |
| Net margin | 6.2% | 5.4% | 3.9% | 3.5% | 3.7% | 13.3% |
| Return on equity | 11.9% | 12.0% | 9.0% | 8.8% | 8.6% | 8.9% |
| Return on assets | 5.7% | 6.5% | 4.7% | 3.8% | 6.2% | 6.1% |
| Free cash flow yield | 47.9% | 43.6% | 34.5% | 38.3% | 9.4% | 17.4% |
| Revenue growth | -8.3% | -0.2% | -0.6% | 329.5% | 264.7% | 6.4% |
| Earnings growth | 3.8% | 39.1% | 11.4% | 299.8% | 2.3% | -0.6% |
| Current ratio | 0.95x | 1.15x | 1.06x | 0.85x | 1.85x | 1.31x |
| Debt to equity | 0.29x | 0.35x | 0.56x | 0.65x | 1.56x | 0.19x |
| Equity ratio | 47.7% | 54.1% | 52.6% | 43.0% | 71.8% | 68.9% |
| Interest coverage | 15.93x | 10.56x | 4.76x | 5.35x | 3.22x | 11.21x |
| R&D as a share of sales | 1.2% | 1.0% | 1.0% | 1.0% | 2.5% | 5.3% |
| Buybacks as a share of market value | -0.0% | 0.1% | -26.3% | -30.4% | -36.6% | -0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -3.1% | 70.1% | 36.1% |
| Operating income | -3.6% | 52.2% | — |
| Net income | 17.2% | 45.8% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 16.8% | 16.1% | 16.5% | 16.6% |
| Operating margin | 7.6% | 7.1% | 7.2% | 6.4% |
| Net margin | 5.8% | 4.7% | 4.8% | 4.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 11.8 | 11.4 | 11.4 | 12.8 | 41.4 | 24.8 | 21.9 | 47.9 | -18.9 | 186.9 |
| Price to sales | 0.7 | 0.6 | 0.5 | 0.5 | 1.6 | 3.3 | 3.1 | 2.4 | 4.3 | 6.7 |
Dividends and splits
Per share, in the currency the company pays
Paid for 2 years. Last went ex-dividend on 23 Jun 2025.
| FY2025 | FY2024 | FY2010 | FY2007 | FY2005 | FY2004 | FY2002 | FY2001 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.38 | 0.38 | 0.15 | 0.03 | 0.05 | 0.15 | 0.063 | 0.063 |
- 1-to-1 reverse split · 28 Nov 2005
- 8-for-5 split · 21 May 2004
- 13-for-10 split · 25 Apr 2001
- 13-for-10 split · 21 Jul 2000
- 13-for-10 split · 10 Jun 1998
- 8-for-5 split · 31 Mar 1997
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.